Clinical Trials Directory

Trials / Terminated

TerminatedNCT02136927

Bioavailability Study of SPARC1210 and Reference1210 in Subjects With Metastatic Breast Cancer

Status
Terminated
Phase
Phase 1
Study type
Interventional
Enrollment
33 (actual)
Sponsor
Sun Pharma Advanced Research Company Limited · Industry
Sex
Female
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

Pharmacokinetic, bioequivalence study

Conditions

Interventions

TypeNameDescription
DRUGSPARC1210
DRUGReference1210

Timeline

Start date
2014-08-01
Primary completion
2016-04-01
Completion
2016-04-01
First posted
2014-05-13
Last updated
2019-05-03

Locations

12 sites across 1 country: India

Source: ClinicalTrials.gov record NCT02136927. Inclusion in this directory is not an endorsement.

Bioavailability Study of SPARC1210 and Reference1210 in Subjects With Metastatic Breast Cancer (NCT02136927) · Clinical Trials Directory